Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Benjamin Watkins(Emory University), Leslie S. Kean(Boston Children's Hospital), Michael A. Pulsipher(Primary Children's Hospital), Maxim Norkin(University of Florida Health), Courtney McCracken(Emory University), Brandi Bratrude(Boston Children's Hospital), Kayla Cribbin(Seattle Children's Hospital), Edmund K. Waller(Emory University), Catherine Bresee(Cedars-Sinai Medical Center), Kayla Betz(Boston Children's Hospital), Nosha Farhadfar(University of Florida Health), Scott N. Furlan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), James L.M. Ferrara(Tisch Hospital), Ted Gooley(Fred Hutch Cancer Center), Andrew C. Harris(Primary Children's Hospital), Mourad Tighiouart(Cedars-Sinai Medical Center), Michael Grimley(Cincinnati Children's Hospital Medical Center), Alexandria Narayan(Fred Hutch Cancer Center), Muna Qayed(Emory University), Alison Yu(Boston Children's Hospital), Shauna Sinclair(Seattle Children's Hospital), John E. Levine(Icahn School of Medicine at Mount Sinai), Steven E. Bosinger(Emory University), Roger Giller(Center for Cancer and Blood Disorders), Amelia Langston(CancerCare Manitoba), James Rhodes(Aflac (United States)), Bruce R. Blazar(University of Minnesota Medical Center), John Horan(Emory University), Sung Won Choi(University of Michigan), Yvonne Suessmuth(Emory University), Kirk R. Schultz(University of British Columbia), Shalini Shenoy(St. Louis Children's Hospital), David A. Jacobsohn(Children's National), Kyle Hebert(Harvard University), Audrey G. Tumlin(Aflac (United States)), Urvi Kapoor(Icahn School of Medicine at Mount Sinai), Nahal Lalefar(University of California, San Francisco), Gregory A. Yanik(University of Michigan), Marcelo C. Pasquini(Cleveland Clinic), Scott Gillespie(Emory University), André Rogatko(Cedars-Sinai Medical Center), Sungjin Kim(Cedars-Sinai Medical Center), Aleksandra Petrović(Seattle Children's Hospital), Jeffrey Davis(BC Children's Hospital), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Victor Tkachev(Boston Children's Hospital)
Cited by 247
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k